11 Females must not be lactating or pregnant at Screening or Baseline as documented by a negative beta-human chorionic gonadotropin B-hCG or a human chorionic gonadotropin hCG test with a minimum sensitivity of 25 IU/L or equivalent units of B-hCG or hCG A separate baseline assessment is required if a negative screening pregnancy test was obtained more than 72 hours before the first dose of study drug 